Nivolumab Wins First-Line Indication in Metastatic UC

The FDA approved nivolumab alongside cisplatin and gemcitabine in the frontline for adults with unresectable or metastatic disease.
Medscape Medical News

source https://www.medscape.com/viewarticle/nivolumab-wins-first-line-indication-metastatic-urothelial-2024a10004g4?src=rss